Home > Boards > US OTC > Biotechs > Ampio Pharmaceuticals, Inc (AMPE)

big run coming

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
m1999 Member Profile
Member Level 
Followed By 798
Posts 58,399
Boards Moderated 43
Alias Born 03/10/09
160x600 placeholder
Ampio Provides Update on AP-013 Phase III Clinical Trial and Annual Meeting Conference Call Number PR Newswire (US) - 12/4/2019 8:30:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/7/2019 4:34:23 PM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 10/31/2019 4:31:35 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/29/2019 6:03:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/21/2019 4:36:09 PM
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) Edgar (US Regulatory) - 10/16/2019 4:03:18 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/10/2019 4:02:31 PM
Ampio Provides Update on Continued Progress of AP-013 Phase III Clinical Trial and Manufacturing Facility PR Newswire (US) - 10/10/2019 8:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/20/2019 4:02:57 PM
Ampio Retains Legal Counsel for Transaction Advisory Committee PR Newswire (US) - 9/18/2019 8:30:00 AM
Ampio Pharmaceuticals Updates Progress of SPA Clinical Trial PR Newswire (US) - 9/17/2019 8:30:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/11/2019 5:47:09 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/11/2019 5:32:22 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/11/2019 5:13:54 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/23/2019 4:03:17 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/22/2019 3:05:35 PM
Ampio Pharmaceuticals Retains Financial Advisor and Appoints Transaction Advisory Committee PR Newswire (US) - 8/22/2019 8:30:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/9/2019 4:04:18 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/1/2019 5:23:37 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 8/1/2019 5:01:31 PM
Ampio Pharmaceuticals Updates Progress of SPA Clinical Trial PR Newswire (US) - 7/25/2019 8:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/11/2019 4:02:23 PM
Ampio Appoints Moss Adams LLP as the Company's New Independent Auditor PR Newswire (US) - 7/11/2019 8:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/10/2019 4:03:12 PM
Ampio Appoints Dan Stokely as the Company's new Chief Financial Officer PR Newswire (US) - 7/10/2019 8:30:00 AM
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
© 2019 InvestorsHub.com, Inc.